Clinical trial
Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients…
NCT00004487 · FDA Office of Orphan Products Development, U.S. Fed · Unknown status
Key facts
| NCT number | NCT00004487 |
|---|---|
| Title | Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux |
| Lead sponsor | FDA Office of Orphan Products Development, U.S. Fed |
| Collaborators | Curis, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vesicoureteral Reflux |
| Intervention type | Drug |
| Interventions | chondrocyte-alginate gel suspension |
| Enrollment | 60 |
| Start date | May 1, 1999 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: